Volver a Agenda
TOPIC 2 SESSION 5: Expedited Reporting Requirements in the Post-authorisation Phase and Case Studies
Session Chair(s)
Gaby L. Danan, MD, PHD
Pharmacovigilance Expert
GLD, France
Phil Tregunno
Deputy Director - Patient Safety Monitoring
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Speaker(s)
Expedited Reporting Requirements in the Post-authorisation Phase and Case Studies
Gaby L. Danan, MD, PHD
GLD, France
Pharmacovigilance Expert
¿Tiene una cuenta?